Yinchenhao decoction in the treatment of cholestasis: A systematic review and meta-analysis

被引:29
作者
Chen, Zhe [1 ,2 ]
Ma, Xiao [1 ,2 ]
Zhao, Yanling [1 ]
Wang, Jiabo [1 ]
Zhang, Yaming [1 ]
Li, Jianyu [3 ]
Wang, Ruilin [3 ]
Zhu, Yun [3 ]
Wang, Lifu [3 ]
Xiao, Xiaohe [1 ]
机构
[1] China Mil Inst Chinese Med, Chengdu 611137, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu 611137, Peoples R China
[3] 302 Mil Hosp China, Dept Integrat Med Ctr, Beijing 100039, Peoples R China
关键词
Cholestasis; Yinchenhao decoction; Meta-analysis; Efficacy; Safety; TRADITIONAL CHINESE MEDICINE; INCHIN-KO-TO; URSODEOXYCHOLIC ACID; OXIDATIVE STRESS; LIVER; PATHOGENESIS; HEPATITIS; FEATURES;
D O I
10.1016/j.jep.2015.03.058
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Yinchenhao decoction, a well-known Chinese herbal formula, has been widely used in Chinese Medicine for thousands of years. However, no systematic review of Yinchenhao decoction in treating cholestasis has been completed. This study aims to evaluate the efficacy and safety of the Yinchenhao decoction in treating cholestasis. Materials and methods: The major databases (PubMed, Embase, Cochrane Library, Chinese Biomedical Database, Wanfang database, VIP medicine information system and China National Knowledge Infrastructure) were searched from the databases' inception through November 2014. Randomized controlled trials (RCTs) of Yinchenhao decoction reported in publications for treatment of cholestasis were extracted by two reviewers. The RCTs examined included total efficacy rate and biochemical indices including alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL) and direct bilirubin (DBIL). The Cochrane tool was applied to assess the risk of bias of the trials. The main outcomes of the trials were analyzed using Review Manager 5.3 software. The odds ratio (OR) or mean difference (MD) with a 95% confidence interval (CI) was used to measure the effect. Results: Among the 698 studies identified in the literature search, 15 studies involving 1405 subjects with cholestasis were included in the analysis. Yinchenhao decoction demonstrated efficacy in cholestasis treatment whether in a combined application or not. Additionally, the decoction significantly reduced the elevated levels of cholestasis serum markers, such as ALT, AST, TBIL and DBIL, with a significant difference observed in short and long curative time periods. Remarkably, Yinchenhao decoction displayed a significant efficacy in treating the long-term disease. Conclusion: No serious adverse event was reported. This meta-analysis provides evidence that Yinchenhao decoction is an effective and safe treatment for cholestasis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:208 / 216
页数:9
相关论文
共 41 条
[1]
A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to [J].
Arai, M ;
Yokosuka, O ;
Fukai, K ;
Kanda, T ;
Kojima, H ;
Kawai, S ;
Imazeki, F ;
Hirasawa, H ;
Saisho, H .
HEPATOLOGY RESEARCH, 2004, 28 (03) :161-165
[2]
Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells [J].
Arenas, Fabian ;
Hervias, Isabel ;
Uriz, Miriam ;
Joplin, Ruth ;
Prieto, Jesus ;
Medina, Juan F. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02) :695-709
[3]
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity [J].
Buryova, Halka ;
Chalupsky, Karel ;
Zbodakova, Olga ;
Kanchev, Ivan ;
Jirouskova, Marketa ;
Gregor, Martin ;
Sedlacek, Radislav .
BMC GASTROENTEROLOGY, 2013, 13
[4]
Chinese Medical Association, 2000, INFECT DIS INFORM, V13, P141
[5]
Oxidative Stress and the Pathogenesis of Cholestasis [J].
Copple, Bryan L. ;
Jaeschke, Hartmut ;
Klaassen, Curtis D. .
SEMINARS IN LIVER DISEASE, 2010, 30 (02) :195-204
[6]
Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112
[7]
He J.R., 1959, J CHENGDOU U TRADIT, V1, P42
[8]
Cholestatic liver disease: pathophysiology and therapeutic options [J].
Hofmann, AF .
LIVER, 2002, 22 :14-19
[9]
Huang E., 2013, GUANGZHOU U CHIN MED, V4, P18
[10]
Jiang H.L., 2003, HUBEI U TRADIT CHIN, V5, P2